Cas:31648-35-8 1-benzyl-3,3-dimethylpiperidine-2,4-dione manufacturer & supplier

Chemical Name:1-benzyl-3,3-dimethylpiperidine-2,4-dione

CAS.NO:31648-35-8

Synonyms:1-benzyl-2,4-dioxo-3,3-dimethylpiperidine;1-benzyl-3,3-dimethyl-2,4-piperidinedione;1-Benzyl-3,3-dimethyl-2,4-piperidindion;1-benzyl-3,3-dimethyl-piperidine-2,4-dione

Molecular Formula:C₁₄H₁₇NO₂

Molecular Weight:231.29000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:37.38000

Exact Mass:231.12600

LogP:1.95210

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-benzyl-2,4-dioxo-3,3-dimethylpiperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzyl-3,3-dimethyl-piperidine-2,4-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-benzyl-3,3-dimethyl-piperidine-2,4-dione Use and application,1-benzyl-3,3-dimethyl-piperidine-2,4-dione technical grade,usp/ep/jp grade.

Related News: The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. 1-benzyl-3,3-dimethylpiperidine-2,4-dione manufacturer The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. 1-benzyl-3,3-dimethylpiperidine-2,4-dione supplier The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 1-benzyl-3,3-dimethylpiperidine-2,4-dione vendor As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 1-benzyl-3,3-dimethylpiperidine-2,4-dione factory As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.